Ganciclovir antagonizes the anti-human immunodeficiency virus type 1 activity of zidovudine and didanosine in vitro.

Lignende værker

• Population Pharmacokinetics of Nevirapine, Zidovudine, and Didanosine in Human Immunodeficiency Virus-Infected Patients
  af: Zhou, Xiao-Jian, et al.
  Udgivet: (1999)
• pol mutations conferring zidovudine and didanosine resistance with different effects in vitro yield multiply resistant human immunodeficiency virus type 1 isolates in vivo.
  af: Eron, J J, et al.
  Udgivet: (1993)
• Protection of human immunodeficiency virus encephalitis by a switch from zidovudine to didanosine.
  af: Chrétien, F, et al.
  Udgivet: (1996)
• Didanosine and zidovudine resistance patterns in clinical isolates of human immunodeficiency virus type 1 as determined by a replication endpoint concentration assay.
  af: McLeod, G X, et al.
  Udgivet: (1992)
• Specific, sensitive, and rapid assay for human immunodeficiency virus type 1 pol mutations associated with resistance to zidovudine and didanosine.
  af: Frenkel, L M, et al.
  Udgivet: (1995)